The Communicating CER Evidence for Commercialization & Life Cycle Management Summit

More information about the The Communicating CER Evidence for Commercialization & Life Cycle Management Summit is listed in the event details below. Log in now or scroll down to get extensive content about the The Communicating CER Evidence for Commercialization & Life Cycle Management Summit, including audience size, exhibitors, contact names, booth sizes, pricing information and more. And search Events In America for details on other tradeshows, conferences, meetings, seminars, conventions, fairs, festivals, and events.

In Obama’s health care reform bill, there was a CER Provision in the Patient Protection and Affordable Care Act. This Act allocated $1.1 Billion dollars for CER research which will be overseen by the NIH (National Institute of Health.) Now with the number of CER trials being conducted by the government, Pharma needs to figure out a better way to communicate the CER evidence that is generated when a new drug is launched. Positive CER results can allow a pharmaceutical company to re-negotiate with the payor, assist in positive marketing messages, negotiate with manufacturing companies when developing prices and quality, and also assist in pricing strategies.

Top Reasons To Attend This Conference

1. Develop a clear understanding of the role CER plays in the drug development process including post-approval
2. Learn directly from payers on the role CER evidence has in the reimbursement process
3. Strategies for managing your product when new CER evidence changes overall class efficacy and cost-effectiveness

Contact the event managers listed below for more information about how you can participate at the The Communicating CER Evidence for Commercialization & Life Cycle Management Summit.